{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T05:03:03Z","timestamp":1726290183598},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,17]]},"DOI":"10.7759\/cureus.22324","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T13:26:09Z","timestamp":1645104369000},"source":"Crossref","is-referenced-by-count":1,"title":["Limited Utility of Chemotherapy for Pulmonary Langerhans Cell Histiocytosis Due to Unclear Diagnostic Criteria"],"prefix":"10.7759","author":[{"given":"Tanjot S","family":"Saini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharad K","family":"Dass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simran","family":"Dhillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.55.5.405","article-title":"Adult pulmonary Langerhans' cell histiocytosis","volume":"55","author":"Tazi A","year":"2000","unstructured":"Tazi A, Soler P, Hance AJ. Adult pulmonary Langerhans' cell histiocytosis. Thorax. 2000, 55:405-16. 10.1136\/thorax.55.5.405","journal-title":"Thorax"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2278::AID-CNCR25>3.0.CO;2-U","article-title":"Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome","volume":"85","author":"Howarth DM","year":"1999","unstructured":"Howarth DM, Gilchrist GS, Mullan BP, Wiseman GA, Edmonson JH, Schomberg PJ. Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer. 1999, 85:2278-90.","journal-title":"Cancer"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1097\/00005792-198111000-00001","article-title":"Eosinophilic granuloma of lung. Clinical aspects of primary histiocytosis in the adult","volume":"60","author":"Friedman PJ","year":"1981","unstructured":"Friedman PJ, Liebow AA, Sokoloff J. Eosinophilic granuloma of lung. Clinical aspects of primary histiocytosis in the adult. Medicine (Baltimore). 1981, 60:385-96.","journal-title":"Medicine (Baltimore)"},{"key":"ref4","article-title":"Pulmonary Langerhans cell histiocytosis","author":"King TE","year":"2021","unstructured":"King TE, Flaherty KR. Pulmonary Langerhans cell histiocytosis. UpToDate. Post TW (ed): UpToDate, Waltham, MA; 2021."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000141","article-title":"Pulmonary langerhans cell histiocytosis: case series and literature review","volume":"93","author":"Wei P","year":"2014","unstructured":"Wei P, Lu HW, Jiang S, Fan LC, Li HP, Xu JF. Pulmonary langerhans cell histiocytosis: case series and literature review. Medicine (Baltimore). 2014, 93:e141. 10.1097\/MD.0000000000000141","journal-title":"Medicine (Baltimore)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-91-3-397","article-title":"Circulating immune complexes in pulmonary eosinophilic granuloma","volume":"91","author":"King TE Jr","year":"1979","unstructured":"King TE Jr, Schwarz MI, Dreisin RE, Pratt DS, Theofilopoulos AN. Circulating immune complexes in pulmonary eosinophilic granuloma. Ann Intern Med. 1979, 91:397-9. 10.7326\/0003-4819-91-3-397","journal-title":"Ann Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200105000-00010","article-title":"Pulmonary Langerhans' cell histiocytosis: molecular analysis of clonality","volume":"25","author":"Yousem SA","year":"2001","unstructured":"Yousem SA, Colby TV, Chen YY, Chen WG, Weiss LM. Pulmonary Langerhans' cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol. 2001, 25:630-6. 10.1097\/00000478-200105000-00010","journal-title":"Am J Surg Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114782","article-title":"Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophilic granuloma","volume":"86","author":"Aguayo SM","year":"1990","unstructured":"Aguayo SM, King TE Jr, Waldron JA Jr, Sherritt KM, Kane MA, Miller YE. Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophilic granuloma. J Clin Invest. 1990, 86:838-44. 10.1172\/JCI114782","journal-title":"J Clin Invest"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0070-2017","article-title":"How I manage pulmonary Langerhans cell histiocytosis","volume":"26","author":"Lorillon G","year":"2017","unstructured":"Lorillon G, Tazi A. How I manage pulmonary Langerhans cell histiocytosis. Eur Respir Rev. 2017, 26:145. 10.1183\/16000617.0070-2017","journal-title":"Eur Respir Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2015-0246-RA","article-title":"Pulmonary Langerhans cell histiocytosis: an update from the pathologists' perspective","volume":"140","author":"Roden AC","year":"2016","unstructured":"Roden AC, Yi ES. Pulmonary Langerhans cell histiocytosis: an update from the pathologists' perspective. Arch Pathol Lab Med. 2016, 140:230-40. 10.5858\/arpa.2015-0246-RA","journal-title":"Arch Pathol Lab Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2490","article-title":"Pulmonary Langerhans cell histiocytosis-associated pulmonary hypertension: clinical characteristics and impact of pulmonary arterial hypertension therapies","volume":"142","author":"Le Pavec J","year":"2012","unstructured":"Le Pavec J, Lorillon G, Ja\u00efs X, et al.. Pulmonary Langerhans cell histiocytosis-associated pulmonary hypertension: clinical characteristics and impact of pulmonary arterial hypertension therapies. Chest. 2012, 142:1150-7. 10.1378\/chest.11-2490","journal-title":"Chest"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006293422607","article-title":"Pulmonary Langerhans'-cell histiocytosis","volume":"342","author":"Vassallo R","year":"2000","unstructured":"Vassallo R, Ryu JH, Colby TV, Hartman T, Limper AH. Pulmonary Langerhans'-cell histiocytosis. N Engl J Med. 2000, 342:1969-78. 10.1056\/NEJM200006293422607","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1148\/radiographics.12.3.1609142","article-title":"Imaging of pulmonary histiocytosis X","volume":"12","author":"Kulwiec EL","year":"1992","unstructured":"Kulwiec EL, Lynch DA, Aguayo SM, Schwarz MI, King TE Jr. Imaging of pulmonary histiocytosis X. Radiographics. 1992, 12:515-26. 10.1148\/radiographics.12.3.1609142","journal-title":"Radiographics"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1378\/chest.115.5.1452","article-title":"Pulmonary Langerhans' cell histiocytosis: radiologic resolution following smoking cessation","volume":"115","author":"Mogulkoc N","year":"1999","unstructured":"Mogulkoc N, Veral A, Bishop PW, Bayindir U, Pickering CA, Egan JJ. Pulmonary Langerhans' cell histiocytosis: radiologic resolution following smoking cessation. Chest. 1999, 115:1452-5. 10.1378\/chest.115.5.1452","journal-title":"Chest"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00146114","article-title":"Cladribine improves lung cysts and pulmonary function in a child with histiocytosis","volume":"45","author":"Epaud R","year":"2015","unstructured":"Epaud R, Ducou Le Pointe H, Fasola S, Ploussard S, Delestrain C, Sileo C, Donadieu J. Cladribine improves lung cysts and pulmonary function in a child with histiocytosis. Eur Respir J. 2015, 45:831-3. 10.1183\/09031936.00146114","journal-title":"Eur Respir J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25277","article-title":"Vemurafenib in Langerhans cell histiocytosis: report of a pediatric patient and review of the literature","volume":"9","author":"Heisig A","year":"2018","unstructured":"Heisig A, S\u00f6rensen J, Zimmermann SY, et al.. Vemurafenib in Langerhans cell histiocytosis: report of a pediatric patient and review of the literature. Oncotarget. 2018, 9:22236-40. 10.18632\/oncotarget.25277","journal-title":"Oncotarget"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.01.17101220","article-title":"Smoking-related interstitial lung diseases: a concise review","volume":"17","author":"Ryu JH","year":"2001","unstructured":"Ryu JH, Colby TV, Hartman TE, Vassallo R. Smoking-related interstitial lung diseases: a concise review. Eur Respir J. 2001, 17:122-32. 10.1183\/09031936.01.17101220","journal-title":"Eur Respir J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s13244-014-0338-0","article-title":"Pulmonary Langerhans cell histiocytosis: the many faces of presentation at initial CT scan","volume":"5","author":"Castoldi MC","year":"2014","unstructured":"Castoldi MC, Verrioli A, De Juli E, Vanzulli A. Pulmonary Langerhans cell histiocytosis: the many faces of presentation at initial CT scan. Insights Imaging. 2014, 5:483-92. 10.1007\/s13244-014-0338-0","journal-title":"Insights Imaging"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-014-0191-8","article-title":"Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis","volume":"9","author":"Grobost V","year":"2014","unstructured":"Grobost V, Khouatra C, Lazor R, Cordier JF, Cottin V. Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis. Orphanet J Rare Dis. 2014, 9:191. 10.1186\/s13023-014-0191-8","journal-title":"Orphanet J Rare Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000249443.82971.bb","article-title":"Immunohistochemical analysis of langerin in langerhans cell histiocytosis and pulmonary inflammatory and infectious diseases","volume":"31","author":"Sholl LM","year":"2007","unstructured":"Sholl LM, Hornick JL, Pinkus JL, Pinkus GS, Padera RF. Immunohistochemical analysis of langerin in langerhans cell histiocytosis and pulmonary inflammatory and infectious diseases. Am J Surg Pathol. 2007, 31:947-52. 10.1097\/01.pas.0000249443.82971.bb","journal-title":"Am J Surg Pathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/80834-limited-utility-of-chemotherapy-for-pulmonary-langerhans-cell-histiocytosis-due-to-unclear-diagnostic-criteria","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:46:29Z","timestamp":1707507989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/80834-limited-utility-of-chemotherapy-for-pulmonary-langerhans-cell-histiocytosis-due-to-unclear-diagnostic-criteria"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.22324","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,17]]}}}